ImmunoBrain Checkpoint Inc., a clinical stage biopharmaceutical company developing disease-modifying immune therapies to combat neurodegenerative diseases, has appointed Dr. Sanjay Keswani, MD, BSc, FRCP, as its president and chief executive officer.   Dr. Keswani is an accomplished physician-scientist with executive leadership experience in both large pharma and small biotech companies. He is a former Neurology faculty member at The Johns Hopkins Hospital and an elected Fellow of the Royal Co...